Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam Inc
(NQ:
BEAT
)
2.180
-0.080 (-3.54%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Heartbeam Inc
< Previous
1
2
3
4
Next >
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms
May 25, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
May 25, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution
May 18, 2023
Via
Investor Brand Network
Exposures
Product Safety
Heartbeam Inc. (NASDAQ: BEAT) Near the Top of Equities by Percentage Gain on 3/20
March 20, 2023
Via
Investor Brand Network
Topics
Credit Cards
Exposures
Interest Rates
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System
May 18, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates
May 12, 2023
Via
Investor Brand Network
Exposures
Product Safety
HeartBeam Reports First Quarter 2023 Financial Results
May 11, 2023
From
HeartBeam, Inc.
Via
Business Wire
$25 Million Capital Raise Completed to Support Commercialization of Unique 3-D Telehealth Technology for Heart Attack Detection and Rapid Response: HeartBeam, Inc. (NASDAQ: BEAT)
May 03, 2023
Via
Get News
Topics
Credit Cards
Exposures
Interest Rates
Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway
May 03, 2023
Via
Investor Brand Network
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
May 03, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Offer Timely Solution amid a ‘Smoldering Public Health Crisis’
March 30, 2023
Via
Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients
March 24, 2023
Via
Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults
March 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q4, FY 2022 Financial Report, Corporate Updates
March 17, 2023
Via
Investor Brand Network
Topics
Earnings
Intellectual Property
Exposures
Financial
Intellectual Property
Product Safety
HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Acquires LIVEMOR Assets
March 14, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
HeartBeam Announces Acquisition of LIVMOR Assets
March 14, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products
March 13, 2023
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Makes Changes in Senior Leadership Roles
March 08, 2023
Via
Investor Brand Network
Exposures
Product Safety
HeartBeam Announces Senior Leadership Change
March 08, 2023
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact
March 03, 2023
Via
Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call
March 02, 2023
Via
Investor Brand Network
HeartBeam to Host Fourth Quarter and Full Year 2022 Results Conference Call on Thursday March 16, 2023 at 4:30 p.m. Eastern Time
March 02, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview
February 21, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions
February 21, 2023
Via
Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks
February 03, 2023
Via
Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President
January 24, 2023
Via
Investor Brand Network
HeartBeam Appoints Robert Eno as President
January 24, 2023
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space
January 24, 2023
Via
Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Growing Patent Portfolio Poised to Have Disruptive Effect on Multibillion Markets
January 19, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.